VMP 42293311000001101

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Co-amilofruse 2.5mg/20mg tablets
BNF code 0202040B0AAABAB
Virtual Therapeutic Moiety Co-amilofruse
Date identifier became valid 29 Sep 2023
Previous product identifier 318135008
Basis of preferred name BAN - British Approved Name
Date of name applicability 4 May 2004
Previous name Co-amilofruse 2.5/20 tablets
Basis of previous name BAN - British Approved Name
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Amiloride hydrochloride
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 2.500
Strength value numerator unit mg
Virtual Product Ingredient
Ingredient Furosemide
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 20.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Co-amilofruse 2.5mg/20mg tablets (A A H Pharmaceuticals Ltd)
Co-amilofruse 2.5mg/20mg tablets (Alliance Healthcare (Distribution) Ltd)
Co-amilofruse 2.5mg/20mg tablets (Medihealth (Northern) Ltd)
Co-amilofruse 2.5mg/20mg tablets (Milpharm Ltd)
Co-amilofruse 2.5mg/20mg tablets (Phoenix Healthcare Distribution Ltd)
Co-amilofruse 2.5mg/20mg tablets (Sigma Pharmaceuticals Plc)
Co-amilofruse 2.5mg/20mg tablets (Wockhardt UK Ltd)
Virtual Medicinal Product Packs
Co-amilofruse 2.5mg/20mg tablets 28 tablet
Co-amilofruse 2.5mg/20mg tablets 56 tablet

dm+d data retrieved from TRUD: release NHSBSA_4.4.0_20240429000001, imported on 29th April 2024 at 05:07:25.

Feedback